1.
Blood Adv
; 2022 Apr 04.
Article
in English
| MEDLINE | ID: covidwho-2231185
2.
Blood
; 138(16): 1386-1387, 2021 10 21.
Article
in English
| MEDLINE | ID: covidwho-1560565
3.
J Thromb Haemost
; 19(8): 2094-2095, 2021 08.
Article
in English
| MEDLINE | ID: covidwho-1358619
4.
J Thromb Haemost
; 19(6): 1585-1588, 2021 06.
Article
in English
| MEDLINE | ID: covidwho-1247252
ABSTRACT
Vaccine administration is under way worldwide to combat the current COVID-19 pandemic. The newly developed vaccines are highly effective with minimal adverse effects. Recently, the AstraZeneca ChadOx1 nCov-19 vaccine has raised public alarm with concerns regarding the rare, but serious, development of thrombotic events, now known as vaccine-induced immune thrombotic thrombocytopenia (VITT). These thrombotic events appear similar to heparin-induced thrombocytopenia, both clinically and pathologically. In this manuscript, the ISTH SSC Subcommittee on Platelet Immunology outlines guidelines on how to recognize, diagnose and manage patients with VITT.
Subject(s)
COVID-19 , Vaccines , COVID-19 Vaccines , ChAdOx1 nCoV-19 , Clinical Laboratory Techniques , Communication , Humans , Pandemics , SARS-CoV-2
5.
Thromb Res
; 203: 1-4, 2021 07.
Article
in English
| MEDLINE | ID: covidwho-1199094